AIM IMMUNOTECH INC. Comprehensive Income
AIM IMMUNOTECH INC. (AIM) reported Comprehensive Income of -$17.32 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-03-27
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$5.97M.
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$3.70M.
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$1.84M.
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$5.82M.
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$17.32M.
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$28.96M.
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$19.45M.
- AIM IMMUNOTECH INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$19.08M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$5.97M derived: 10-K 12 month − 3 quarters · filed 2025-03-27 | -$9.67M derived: sum of 2 quarters · filed 2025-03-27 | -$11.50M derived: sum of 3 quarters · filed 2025-03-27 | -$17.32M 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | -$3.70M 10-Q · filed 2024-11-14 | -$5.54M derived: sum of 2 quarters · filed 2024-11-14 | -$11.35M derived: sum of 3 quarters · filed 2024-11-14 | -$23.93M derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2024-06-30 | -$1.84M 10-Q · filed 2024-11-14 | -$7.65M derived: sum of 2 quarters · filed 2024-11-14 | -$20.23M derived: sum of 3 quarters · filed 2025-03-27 | -$28.05M derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2024-03-31 | -$5.82M 10-Q · filed 2024-11-14 | -$18.39M derived: sum of 2 quarters · filed 2025-03-27 | -$26.21M derived: sum of 3 quarters · filed 2025-03-27 | -$31.12M derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2023-12-31 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$20.39M derived: sum of 2 quarters · filed 2025-03-27 | -$25.30M derived: sum of 3 quarters · filed 2025-03-27 | -$28.96M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$7.82M 10-Q · filed 2024-11-14 | -$12.72M derived: sum of 2 quarters · filed 2024-11-14 | -$16.39M 10-Q · filed 2023-11-14 | -$20.77M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$4.91M 10-Q · filed 2024-11-14 | -$8.57M derived: sum of 2 quarters · filed 2024-11-14 | -$12.96M derived: sum of 3 quarters · filed 2024-11-14 | -$19.34M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-03-31 | -$3.66M 10-Q · filed 2024-11-14 | -$8.05M derived: sum of 2 quarters · filed 2024-11-14 | -$14.44M derived: sum of 3 quarters · filed 2024-11-14 | -$19.29M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2022-12-31 | -$4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$10.77M derived: sum of 2 quarters · filed 2024-04-01 | -$15.63M derived: sum of 3 quarters · filed 2024-04-01 | -$19.45M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$6.38M 10-Q · filed 2023-11-14 | -$11.24M derived: sum of 2 quarters · filed 2023-11-14 | -$15.06M 10-Q · filed 2023-11-14 | -$20.65M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$4.85M 10-Q · filed 2023-08-14 | -$8.67M 10-Q · filed 2022-08-15 | -$14.27M derived: sum of 3 quarters · filed 2023-08-14 | -$18.10M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$3.82M 10-Q · filed 2023-08-14 | -$9.42M derived: sum of 2 quarters · filed 2023-08-14 | -$13.24M derived: sum of 3 quarters · filed 2023-08-14 | -$19.16M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2021-12-31 | -$5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$9.43M derived: sum of 2 quarters · filed 2023-03-31 | -$15.34M derived: sum of 3 quarters · filed 2023-03-31 | -$19.08M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$3.83M 10-Q · filed 2022-11-14 | -$9.74M derived: sum of 2 quarters · filed 2022-11-14 | -$13.48M 10-Q · filed 2022-11-14 | -$17.45M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$5.91M 10-Q · filed 2022-11-14 | -$9.65M 10-Q · filed 2022-08-15 | -$13.62M derived: sum of 3 quarters · filed 2022-11-14 | -$17.00M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-03-31 | -$3.74M 10-Q · filed 2022-11-14 | -$3.74M 10-Q · filed 2021-05-17 | -$7.71M derived: sum of 2 quarters · filed 2022-11-14 | -$11.09M derived: sum of 3 quarters · filed 2022-11-14 | -$14.39M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2020-12-31 | -$3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$7.35M derived: sum of 2 quarters · filed 2022-03-31 | -$10.65M derived: sum of 3 quarters · filed 2022-03-31 | -$14.45M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$3.38M 10-Q · filed 2021-11-15 | -$6.68M derived: sum of 2 quarters · filed 2021-11-15 | -$10.48M 10-Q · filed 2021-11-15 | -$10.48M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$3.30M 10-Q · filed 2021-11-15 | -$7.10M 10-Q · filed 2021-08-16 | -$7.10M derived: sum of 3 quarters · filed 2021-11-15 | -$10.04M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-03-31 | -$3.79M 10-Q · filed 2021-11-15 | -$3.81M 10-Q · filed 2020-05-14 | -$3.79M derived: sum of 2 quarters · filed 2021-11-15 | -$6.74M derived: sum of 3 quarters · filed 2021-11-15 | -$8.78M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2021-03-31 | -$2.95M derived: sum of 2 quarters · filed 2021-03-31 | -$4.98M derived: sum of 3 quarters · filed 2021-03-31 | -$9.40M 10-K · filed 2021-03-31 | -$9.53M 10-K · filed 2020-03-30 | |||
| 2019-09-30 | -$2.95M 10-Q · filed 2020-11-12 | -$4.98M derived: sum of 2 quarters · filed 2020-11-12 | -$9.40M 10-K · filed 2021-03-31 | -$8.34M 10-Q · filed 2019-11-14 | -$9.96M derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | -$2.04M 10-Q · filed 2020-08-14 | -$5.39M 10-Q · filed 2020-08-14 | -$7.01M derived: sum of 3 quarters · filed 2020-08-14 | -$10.08M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$3.37M 10-Q · filed 2020-05-14 | -$4.97M derived: sum of 2 quarters · filed 2020-05-14 | -$8.04M derived: sum of 3 quarters · filed 2020-05-14 | -$10.49M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$4.68M derived: sum of 2 quarters · filed 2020-03-30 | -$7.13M derived: sum of 3 quarters · filed 2020-03-30 | -$9.83M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$3.07M 10-Q · filed 2019-11-14 | -$5.52M derived: sum of 2 quarters · filed 2019-11-14 | -$8.22M 10-Q · filed 2019-11-14 | -$10.25M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$2.45M 10-Q · filed 2019-08-14 | -$5.15M 10-Q · filed 2019-08-14 | -$7.18M derived: sum of 3 quarters · filed 2019-08-14 | -$8.43M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$2.73M 10-Q · filed 2019-05-15 | -$4.74M derived: sum of 2 quarters · filed 2019-05-15 | -$5.98M derived: sum of 3 quarters · filed 2019-05-15 | -$8.16M derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$3.25M derived: sum of 2 quarters · filed 2019-04-01 | -$5.43M derived: sum of 3 quarters · filed 2019-04-01 | -$8.24M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | -$1.24M 10-Q · filed 2018-11-14 | -$3.42M derived: sum of 2 quarters · filed 2018-11-14 | -$6.23M 10-Q · filed 2018-11-14 | -$7.48M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | -$2.18M 10-Q · filed 2018-08-14 | -$4.99M 10-Q · filed 2018-08-14 | -$4.92M 10-Q · filed 2017-08-14 | -$6.24M derived: sum of 3 quarters · filed 2018-08-14 | -$9.12M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | -$2.81M 10-Q · filed 2018-05-15 | -$4.06M derived: sum of 2 quarters · filed 2018-05-15 | -$6.94M derived: sum of 3 quarters · filed 2018-05-15 | -$8.20M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$4.13M derived: sum of 2 quarters · filed 2018-03-30 | -$5.39M derived: sum of 3 quarters · filed 2018-03-30 | -$7.41M 10-K · filed 2018-03-30 | ||||
| 2016-09-30 | -$2.88M 10-Q · filed 2017-11-14 | -$4.14M derived: sum of 2 quarters · filed 2017-11-14 | -$6.16M 10-Q · filed 2017-11-14 | -$8.99M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-06-30 | -$1.26M 10-Q · filed 2017-08-14 | -$3.28M 10-Q · filed 2017-08-14 | -$6.12M derived: sum of 3 quarters · filed 2018-03-30 | -$10.13M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2016-03-31 | -$2.02M 10-Q · filed 2017-05-15 | -$4.85M derived: sum of 2 quarters · filed 2018-03-30 | -$8.87M derived: sum of 3 quarters · filed 2018-03-30 | -$13.85M derived: sum of 4 quarters · filed 2018-03-30 | ||||
| 2015-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$6.85M derived: sum of 2 quarters · filed 2018-03-30 | -$11.83M derived: sum of 3 quarters · filed 2018-03-30 | -$15.17M 10-K · filed 2018-03-30 | ||||
| 2015-09-30 | -$4.02M 10-Q · filed 2016-11-14 | -$9.00M derived: sum of 2 quarters · filed 2016-11-14 | -$12.33M 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$4.98M 10-Q · filed 2016-08-15 | -$8.32M 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | -$3.33M 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | -$17.50M 10-K · filed 2017-03-31 | |||||||
| 2013-12-31 | -$16.30M 10-K · filed 2016-03-29 | |||||||
| 2011-09-30 | -$3.27M 10-Q · filed 2011-11-09 | -$5.79M 10-Q · filed 2011-11-09 | ||||||
| 2010-09-30 | -$3.12M 10-Q · filed 2011-11-09 | -$9.92M 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |